Strides Pharma Q3 Results: PAT rises over 2-fold at Rs 208.12 crore by ET Markets | January 30, 2026 3:05 pm | Indian Stocks, Market, News Strides Pharma Science Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 208.12 crore in the third quarter ended December 31, 2025 on the back of robust sales growth and one time income on sale of property.
